NexImmune, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NexImmune, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • NexImmune, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $281K, a 71.7% decline year-over-year.
  • NexImmune, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.35M, a 50.5% decline year-over-year.
  • NexImmune, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.55M, a 39.5% decline from 2022.
  • NexImmune, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.87M, a 1.83% decline from 2021.
  • NexImmune, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.98M, a 391% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.35M $281K -$711K -71.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.06M $348K -$494K -58.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $3.55M $614K -$864K -58.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $4.42M $1.11M -$332K -23.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 $4.75M $991K -$318K -24.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $5.07M $842K -$803K -48.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 $5.87M $1.48M -$192K -11.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $6.06M $1.44M -$191K -11.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 $6.25M $1.31M -$174K -11.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $6.43M $1.65M +$448K +37.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.98M $1.67M +$1.4M +510% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $4.58M $1.63M +$1.34M +472% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $3.24M $1.48M +$1.14M +337% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $2.1M $1.2M +$878K +275% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.22M $274K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 $284K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $340K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $319K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.